Jay Parrish

Jay Parrish has served as Vir Biotechnology’s chief business officer since July 2017 and is one of Vir’s co-founders. He has also been a venture partner at ARCH Venture Partners since May 2016. From September 2011 to May 2016, Jay served in Gilead Sciences, Inc.’s corporate development group, where he was involved in building Gilead’s oncology and infectious disease portfolio, ultimately leading infectious disease business development for the company. He additionally worked as a scientist in Gilead’s medicinal chemistry group, from March 2004 to September 2011. Since 2012, Jay has served as a part-time instructor at the University of California Berkeley Extension, where he teaches chemistry to undergraduates and post-baccalaureates. He also previously completed a postdoctoral fellowship at the Scripps Research Institute. Jay received his B.S. in chemistry from Emory University, a Ph.D. in synthetic organic chemistry from the University of South Florida and an MBA from the University of California, Berkeley Haas School of Business.